JPWO2021132591A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021132591A5 JPWO2021132591A5 JP2021567687A JP2021567687A JPWO2021132591A5 JP WO2021132591 A5 JPWO2021132591 A5 JP WO2021132591A5 JP 2021567687 A JP2021567687 A JP 2021567687A JP 2021567687 A JP2021567687 A JP 2021567687A JP WO2021132591 A5 JPWO2021132591 A5 JP WO2021132591A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022097020A JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン５０のスキッピングを誘導するアンチセンス核酸 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019236704 | 2019-12-26 | ||
| PCT/JP2020/048803 WO2021132591A1 (ja) | 2019-12-26 | 2020-12-25 | エクソン５０のスキッピングを誘導するアンチセンス核酸 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022097020A Division JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン５０のスキッピングを誘導するアンチセンス核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021132591A1 JPWO2021132591A1 (enExample) | 2021-07-01 |
| JPWO2021132591A5 true JPWO2021132591A5 (enExample) | 2024-01-09 |
Family
ID=76574765
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567687A Pending JPWO2021132591A1 (enExample) | 2019-12-26 | 2020-12-25 | |
| JP2022097020A Active JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン５０のスキッピングを誘導するアンチセンス核酸 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022097020A Active JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン５０のスキッピングを誘導するアンチセンス核酸 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20230073008A1 (enExample) |
| EP (1) | EP4083208A4 (enExample) |
| JP (2) | JPWO2021132591A1 (enExample) |
| KR (1) | KR20220122673A (enExample) |
| CN (3) | CN118109468A (enExample) |
| AU (1) | AU2020411964A1 (enExample) |
| BR (1) | BR112022012622A2 (enExample) |
| CA (1) | CA3165961A1 (enExample) |
| CO (1) | CO2022008664A2 (enExample) |
| IL (1) | IL294271A (enExample) |
| MX (1) | MX2022007937A (enExample) |
| MY (1) | MY209476A (enExample) |
| PH (1) | PH12022551431A1 (enExample) |
| TW (2) | TWI874546B (enExample) |
| WO (1) | WO2021132591A1 (enExample) |
| ZA (1) | ZA202206667B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022007491A (es) * | 2019-12-19 | 2022-08-15 | Nippon Shinyaku Co Ltd | Acido nucleico antisentido que permite la omision de exones. |
| AU2020411964A1 (en) * | 2019-12-26 | 2022-06-16 | National Center Of Neurology And Psychiatry | Antisense nucleic acid that induces skipping of exon 50 |
| AU2022424485A1 (en) | 2021-12-27 | 2024-07-11 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
| WO2023168427A1 (en) | 2022-03-03 | 2023-09-07 | Yale University | Compositions and methods for delivering therapeutic polynucleotides for exon skipping |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| DE69033986T2 (de) | 1989-12-20 | 2003-03-13 | Antivirals Inc., Portland | Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten |
| JP2924179B2 (ja) | 1993-02-19 | 1999-07-26 | 日本新薬株式会社 | グリセロール誘導体，デバイス及び医薬組成物 |
| IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
| EP2530155B1 (en) | 2002-11-25 | 2016-03-16 | Masafumi Matsuo | ENA nucleic acid drugs modifying splicing in mRNA precursor |
| SI2206781T1 (sl) | 2004-06-28 | 2016-05-31 | The University Of Western Australia | Protismiselni oligonukleotidi za induciranje preskakovanja eksona in postopki njihove uporabe |
| ES2657400T3 (es) | 2006-05-10 | 2018-03-05 | Sarepta Therapeutics, Inc. | Análogos de oligonucleótidos que tienen enlaces intersubunitarios catiónicos |
| AU2008271050B2 (en) | 2007-06-29 | 2014-11-06 | Sarepta Therapeutics, Inc. | Tissue specific peptide conjugates and methods |
| CA2884340C (en) | 2007-11-15 | 2017-07-25 | Sarepta Therapeutics, Inc. | Method of synthesis of morpholino oligomers |
| EP2762567B1 (en) * | 2008-10-24 | 2016-07-13 | Sarepta Therapeutics, Inc. | Multiple exon skipping compositions for DMD |
| CA2741629C (en) | 2008-10-27 | 2022-07-05 | Academisch Ziekenhuis Leiden | Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna |
| CN101388842B (zh) | 2008-10-30 | 2012-04-04 | 华为技术有限公司 | 一种存储方法和装置 |
| SMT201800579T1 (it) | 2009-11-12 | 2019-01-11 | Univ Western Australia | Molecole antisenso e metodi per trattare patologie |
| TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
| WO2012150960A1 (en) | 2011-05-05 | 2012-11-08 | Avi Biopharma, Inc. | Peptide oligonucleotide conjugates |
| CN108611349A (zh) * | 2011-12-28 | 2018-10-02 | 日本新药株式会社 | 反义核酸 |
| NZ732507A (en) * | 2013-03-15 | 2018-08-31 | Sarepta Therapeutics Inc | Improved compositions for treating muscular dystrophy |
| US10675356B2 (en) | 2015-05-19 | 2020-06-09 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| WO2017024264A2 (en) | 2015-08-05 | 2017-02-09 | Eisai R&D Management Co., Ltd. | Chiral reagents for preparation of homogeneous oligomers |
| SG10201912902TA (en) | 2015-10-09 | 2020-02-27 | Wave Life Sciences Ltd | Oligonucleotide compositions and methods thereof |
| WO2017062835A2 (en) * | 2015-10-09 | 2017-04-13 | Sarepta Therapeutics, Inc. | Compositions and methods for treating duchenne muscular dystrophy and related disorders |
| EP3485015A4 (en) * | 2016-07-15 | 2020-07-29 | Ionis Pharmaceuticals, Inc. | COMPOUNDS AND METHODS OF MODULATION OF DYSTROPHINE TRANSCRIPT |
| HRP20240705T1 (hr) | 2016-12-19 | 2024-08-30 | Sarepta Therapeutics, Inc. | Oligomerni konjugati koji preskaču egzon za mišićnu distrofiju |
| KR102646318B1 (ko) | 2016-12-19 | 2024-03-12 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체 |
| KR102810425B1 (ko) | 2016-12-19 | 2025-05-21 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체 |
| SG11202104960PA (en) | 2018-12-13 | 2021-06-29 | Sarepta Therapeutics Inc | Exon skipping oligomer conjugates for muscular dystrophy |
| AU2020411964A1 (en) * | 2019-12-26 | 2022-06-16 | National Center Of Neurology And Psychiatry | Antisense nucleic acid that induces skipping of exon 50 |
-
2020
- 2020-12-25 AU AU2020411964A patent/AU2020411964A1/en active Pending
- 2020-12-25 MY MYPI2022003210A patent/MY209476A/en unknown
- 2020-12-25 KR KR1020227024957A patent/KR20220122673A/ko active Pending
- 2020-12-25 TW TW109146242A patent/TWI874546B/zh active
- 2020-12-25 PH PH1/2022/551431A patent/PH12022551431A1/en unknown
- 2020-12-25 IL IL294271A patent/IL294271A/en unknown
- 2020-12-25 US US17/788,826 patent/US20230073008A1/en not_active Abandoned
- 2020-12-25 MX MX2022007937A patent/MX2022007937A/es unknown
- 2020-12-25 BR BR112022012622A patent/BR112022012622A2/pt unknown
- 2020-12-25 EP EP20906005.2A patent/EP4083208A4/en active Pending
- 2020-12-25 CN CN202410219725.3A patent/CN118109468A/zh active Pending
- 2020-12-25 TW TW114101879A patent/TW202523843A/zh unknown
- 2020-12-25 CA CA3165961A patent/CA3165961A1/en active Pending
- 2020-12-25 CN CN202080090310.0A patent/CN114901823A/zh active Pending
- 2020-12-25 JP JP2021567687A patent/JPWO2021132591A1/ja active Pending
- 2020-12-25 WO PCT/JP2020/048803 patent/WO2021132591A1/ja not_active Ceased
- 2020-12-25 CN CN202410219814.8A patent/CN118109469A/zh active Pending
-
2022
- 2022-06-15 ZA ZA2022/06667A patent/ZA202206667B/en unknown
- 2022-06-16 JP JP2022097020A patent/JP7201192B2/ja active Active
- 2022-06-22 CO CONC2022/0008664A patent/CO2022008664A2/es unknown
- 2022-06-23 US US17/847,333 patent/US11655472B2/en active Active